Entry into a Material Definitive Agreement

Business Context and Reporting Period

Company: Viewbix Inc. (Note: Metadata referenced "Quantum X Labs Inc." but the filing identifies Viewbix Inc. as the registrant acquiring Quantum X Labs Ltd.)
Reporting Date: December 15, 2025
Event: Entry into a Material Definitive Agreement (Securities Exchange Agreement) to acquire Quantum X Labs Ltd. ("Quantum").

Key Financial Metrics and Transaction Structure

This filing describes a proposed acquisition rather than reporting standard financial performance metrics (revenue, profit, cash flow). The filing text does not provide clear values for Viewbix's current revenue, profit, or debt levels.

Transaction Component Details
Consideration Up to 40.0% of Viewbix's issued and outstanding capital stock.
Viewbix Exchange Shares Up to 2,666,000 shares (approx. 19.99% of outstanding stock).
Pre-Funded Warrants Warrants to purchase up to 4,447,595 shares (exercise price $0.0001).
Target Acquisition Up to 100% (not less than 85%) of Quantum's share capital (up to 589,319 ordinary shares).
Private Placement Includes 800,000 shares previously agreed upon in a Nov 5, 2025 agreement.

Material Changes and Earn-Out Provisions

The transaction represents a material change in corporate structure, with Quantum becoming a subsidiary of Viewbix upon closing. The agreement includes significant contingent consideration ("Earn-Out Securities") totaling up to 12,702,847 additional shares or warrants, issuable only after the 12-month anniversary of the Closing Date if specific milestones are met:

  • Patent Milestone: Up to 1,975,998 shares for submitting 5 patent applications across 3 quantum sub-fields within 18 months.
  • Portfolio Exit Milestone: Up to 3,436,519 shares for a listing, public offering, or M&A of a Portfolio Company at a pre-money valuation of at least $20 million within 24 months.
  • Valuation/Capital Raise Milestone: Up to 7,290,330 shares upon a capital raise or M&A transaction at a pre-money valuation of at least $250 million within 48 months.

Conditions and Restrictions

  • Closing Timeline: Expected within 90 calendar days of the Effective Date.
  • Conditions Precedent: Final due diligence, regulatory approvals, stockholder approval (Nasdaq rules), and execution by shareholders holding at least 85% of Quantum's capital.
  • Lock-Up: Viewbix Exchange Shares and shares from exercised warrants are subject to a 12-month lock-up post-closing.
  • Escrow: Shares issued at closing will be held in escrow for 30 days pending a tax ruling from the Israeli Tax Authority.

Outlook, Risks, and Contingencies

Forward-Looking Statements: The completion of the acquisition is not guaranteed and is subject to customary closing conditions, including regulatory approvals and stockholder votes. The company explicitly states that forward-looking statements are based on present intent and may not occur.

Risks:

  • Failure to obtain necessary regulatory or stockholder approvals.
  • Failure to meet the 85% shareholder execution threshold for Quantum.
  • Significant dilution to existing shareholders due to the issuance of up to 40% of current capital stock plus potential earn-outs.
  • Tax contingencies requiring escrow of shares.

Investor Verification Checklist

  • Verify the exact number of Viewbix shares outstanding as of December 15, 2025, to calculate the precise dilution impact of the 2,666,000 exchange shares.
  • Confirm the status of the 85% shareholder execution requirement for Quantum X Labs Ltd.
  • Review the full text of the Securities Exchange Agreement (Exhibit 10.1) for specific representations and warranties.
  • Monitor the timeline for the 30-day escrow period and the outcome of the Israeli Tax Authority ruling.
  • Assess the feasibility of the earn-out milestones, particularly the $250 million valuation target within 48 months.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.